Bicara Therapeutics Inc. Income Statement

Income Statement Dec2023 Dec2024
Operating items
Research & Development 30.60M63.60M
Selling, General & Administrative 9.27M18.77M
Other Operating Expenses 0.02M0.02M
Operating Expenses 39.89M82.39M
Operating Income -39.89M-82.39M
EBIT -39.89M-82.39M
Non-operating items
Interest & Investment Income 1.31M14.58M
Non Operating Income -12.09M14.58M
Net income details
EBT -51.98M-67.81M
Tax Provisions 0.01M0.18M
Profit After Tax -51.98M-68.00M
Income from Continuing Operations -51.98M-67.99M
Consolidated Net Income -51.98M-67.99M
Income towards Parent Company -51.98M-67.99M
Net Income towards Common Stockholders -51.98M-67.99M
Additional items
EPS (Basic) -0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M
Shares Outstanding (Weighted Average) 34.26M54.42M
EBITDA -39.89M-82.39M